Abbott, Merck, Pfizer raising the bar

Share this article:
Abbott Labs stands out as a leader in marketing research, according to a panel discussion at CBI’s 2nd Annual Pharmaceutical Market Research Summit in Philadelphia at the end of April.

“Their business analysts are very personable and you end up with a tight delivery,” said Peter Simpson, president, Segmedica.

 “They are great at integrating information into what they do daily,” added John Tapper, chief strategy officer, Ziment.

Merck was among the large companies given the thumbs-up by the panel. “Merck is a great example of a company getting, and implementing, strategies in the entire space,” said Meredith Abreu, VP at Manhattan Research. “They are very good at getting information out there.”

Pfizer also drew praise. “The brands act like smaller companies,” said Simpson, “so when you go in you are reporting it your way.”

Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.